Follow us:

News & events

  • Home
  • News & informations

PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!

Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.

  • by Ypso-Facto
  • September 16, 2021
  Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation , Ypso-Facto will develop software solutions to support production of innovative therapies. The company will work on...

Read more

CALIPSO: revolutionizing the management of bioproduction processes in healthcare

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

  • by Ypso-Facto
  • September 15, 2021
  A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence...

Read more

6th Bioproduction Congress

September 30th & October 1st 2021 - Lyon

  • by Ypso-Facto
  • September 07, 2021
Ypso-Facto will participate in the 6 th   Bioproduction Congress ! Theme : Challenges & Opportunities for Biotherapies: lessons learned from COVID-19 pandemic Date  : September 30 th & October 1 st 2021 Location  : L’Espace Tête d’Or - Lyon This annual Conference...

Read more

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information